RNL BIO filed Phase II/III Clinical Trial with KFDA to Treat Cerebral Palsy Using Autologous Fat Derived ... ( SEOUL South Korea Feb. 8 2013 /PR...)

RNL BIO filed Phase II/III Clinical Trial with KFDA to Treat Cerebral Palsy Using Autologous Fat Derived Stem Cells

Date:2/8/2013

SEOUL, South Korea, Feb. 8, 2013 /PRNewswire/ -- RNL BIO CO LTD (RNL) announced today the filing of an Investigational New Drug (IND) application with the Korean Food and Drug Administration (KFDA) to initiate clinical trials phase II and III assessing the company's RNL-Astrostem™ stem cell drug in patients with cerebral palsy. The purpose of this study is to assess conclusive efficacy of stem cells for the treatment of cerebral palsy in 45 subjects over 11 months. The study is to be conducted through Kyung Hee University Hospital at Gangdong and THE Bethesda Hospital.

RNL-Astrostem™, has already completed a phase I trial to assure safety, including tests to rule out toxicity or tumorigenicity. This trial was conducted at the Seoul National University's Clinical Research Institute. In addition, the phase I study has confirmed the safety of stem cells infused by IV, as published in a leading peer-reviewed journal, Stem Cells and Development ("Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans," February 2011). In the course of successful safety trials, scientists found significant evidence suggesting the potential for efficacy of stem cells in treatment of cerebral palsy. In addition, a case report with obvious result of improvement was published in another internationally renowned journal. RNL BIO believes that with successful trials and approval of the KFDA, it will be possible to commercialize RNL-Astrostem™ by 2014, revolutionizing the possibility to cure this incurable disease of children, which can only be managed with current technologies.

Cerebral Palsy is caused by non-progressive brain damage from single or multiple defect(s) on the nerve/muscular system and results in disorder in motion and sensory integration. According to Health Insurance Review and Assessment Service, the prevalence of cerebral palsy is 3.5 pe
'/>"/>

SOURCE RNL BIO
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
2. Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe
3. Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
4. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
5. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
6. Lotus Pharmaceutical Company Inc. Filed Its Abbreviated New Drug Application (ANDA) Containing a Paragraph IV Certification for a Generic Version of Xenical(R) with the U.S. Food & Drug Administration (FDA)
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
11. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease

Post Your Comments:

(Date:5/17/2013)... Biotech Ltd. (Nasdaq: SVA ), a leading provider ... that it will release its unaudited financial results for the ... May 28, 2013. The Company will host a conference call ... 28, 2013 at 8:00 p.m. China Standard Time) to review ... corporate developments. To access the conference call, please ...

(Date:5/16/2013)... Ill. and MECHELEN, Belgium ... GLPG) and AbbVie (NYSE: ABBV ) announced ... to include Crohn,s disease. Galapagos will fund and complete ... designed to facilitate rapid progression into Phase 3. Upon ... AbbVie will pay Galapagos $50 million. The terms of ...

(Date:5/16/2013)... N.C. , May 16, 2013 Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...

Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2 Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6 National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2 National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3

[0] Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results [0] AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease [0] National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill

... Epeius Biotechnologies,announced today the promising results of an on-going ... cancer that is refractory,to conventional chemotherapy (J Clin Oncol ... given i.v. two to,three times a week for 4 ... to 6,x 10e11 cfu per week. The goal of ...

... Communities for Drug Safety,Collaboration" conducting drug safety ... health information to support post-market monitoring efforts, ... eHealth,Initiative (eHI) announced today its support of ... (FDA) on the Sentinel Initiative, a,far-reaching public ...

Cached Medicine Technology:TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008) 2 eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 2 eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 3 eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 4 eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 5

TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative

(Date:5/20/2013)... May 20, 2013 Healing Heart Urgent ... newest office on Briarcliff Road in the Druid Hills ... facility includes Dr. Fidias E. De León M.D. and ... will provide extensive medical services, occupational health, chiropractic care ... Atlanta metropolitan area. They also offer a full range ...

(Date:5/20/2013)... 20, 2013 AURORA, Colo. – May ... accredited university, has developed a Bachelor of Science ... how they feel about continuing their education and gauge ... out the complimentary worksheet, respond to ten statements and ... rate on a BSN-readiness scale. , New industry standards ...

(Date:5/20/2013)... NY (PRWEB) May 20, 2013 InVite® ... City, today announced the introduction of its new ... that provides high density nutrition with plant extracts from ... herbs, spices, royal jelly, apple pectin, plant enzymes and ... offers the micronutrients and antioxidant levels of several servings ...

(Date:5/20/2013)... Can you tell a joke well? , Do people roll their ... like to be funnier as a speaker, teacher, presenter of any ... missing? , Can't think of a snappy comeback when someone hits ... like you, don't worry. Help is here. I believe ... even learn to tell a joke well. I am not kidding. ...

(Date:5/20/2013)... (PRWEB) May 20, 2013 FixturesAndDisplays.com, the ... comprehensive selection of high-quality retail clothing display options to ... and upscale retailers. Their expansive product line includes ... broad range of mannequin options. Recently ... its most popular models in reformulated “green” versions. ...

Breaking Medicine News(10 mins):Health News:Healing Heart Urgent Care Opens New Office In Atlanta 2 Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 2 Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 3 Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 2 Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 3 Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 2 Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 3 Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 4 Health News:FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays 2 Health News:FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays 3

[0] Healing Heart Urgent Care Opens New Office In Atlanta [0] American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness [0] InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™[0] Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke [0] FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays

... , , , ... has been invited to participate in the inaugural Australian Paralympic ... basketball team includes nine athletes and three coaches from Courage ... 5-11 at the Melbourne Sports & Aquatic Centre. The Paralympic ...

... , WASHINGTON, Sept. 23 Speaker Nancy ... Legislative Conference "Capitol Hill Day Summit" this morning in the Capitol ... , , "Thank you, Chairwoman Barbara ... conscience of the Congress. , , "Essential ...

... , STAMFORD, Conn., Sept. 23 AmeriCares this ... States at the 2009 Clinton Global Initiative in New York ... CEO Curt Welling, is a two-year commitment to improve community ... organizations serving the uninsured and underinsured throughout the country. ...

... , , , ... announces their Second Annual Fellowship Convention to be held at ... California. , , Founded in 1998, FA is ... support, are recovering from food addiction. For many people who ...

... series of cases with commentaries by the American ... Rights Committee and the College,s Center for Ethics ... http://cme.medscape.com/viewpublication/30131. "The ethical dilemmas presented are very ... MD, FACP, ACP President. "Learning from case studies ...

... capsules that show a tendency in the standard laboratory test ... and potentially unsafe manner in patients who have consumed alcohol ... with testing in people. That,s the conclusion of a ... Molecular Pharmaceutics , a bi-monthly journal. In ...

Cached Medicine News:Health News:12 Local Athletes and Coaches Chosen for U.S. Wheelchair Basketball Team 2 Health News:Pelosi Remarks at the Congressional Black Caucus Foundation's Annual Legislative Conference 2 Health News:Pelosi Remarks at the Congressional Black Caucus Foundation's Annual Legislative Conference 3 Health News:AmeriCares Expands Medical Assistance Across the United States 2 Health News:AmeriCares Expands Medical Assistance Across the United States 3 Health News:Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World 2 Health News:Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World 3

12 Local Athletes and Coaches Chosen for U.S. Wheelchair Basketball Team Pelosi Remarks at the Congressional Black Caucus Foundation's Annual Legislative Conference AmeriCares Expands Medical Assistance Across the United States Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World ACP launches ethics case studies series on MedscapeCME Medicinal products susceptible to 'dose dumping' should be fully tested

An immunochromatographic test for detection of 4 species of Plasmodium antigen ( P. falciparum , P. vivax , P. malariae , P. ovale ) in whole blood....

Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...

... Biotech Uni-Gold™ Pf Malaria Test is ... the presence of Plasmodium falciparum ... is an antigen-capture assay detecting presence ... rich protein II (PfHRP- II), which ...

High sensitive, specific one step immunochromatographic assay for human infectious disease...

Medicine Products:

PALUTOP+4 Malaria Device / Strip (3 line, PAN-pLDH, P.f.-HRP2)Rapid Uni-Gold™SD Malaria P.f. / P.v. Ag